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a b s t r a c t
Objective: SNPs identiﬁed from genome-wide association studies associate with lipid risk markers of
cardiovascular disease. This study investigated whether these SNPs altered the plasma lipid response to
diet in the ‘RISCK’ study cohort.
Methods: Participants (n=490) from a dietary intervention to lower saturated fat by replacement with
carbohydrate or monounsaturated fat, were genotyped for 39 lipid-associated SNPs. The association of
each individual SNP, and of the SNPs combined (using genetic predisposition scores), with plasma lipid
concentrations was assessed at baseline, and on change in response to 24 weeks on diets.
Results: The associations between SNPs and lipid concentrations were directionally consistent with pre-




of plasma total (P=0.02) and LDL (P=0.002) cholesterol, triglycerides (P=0.001) and apolipoprotein B
(P=0.004), and with lower baseline concentrations of HDL cholesterol (P<0.001) and apolipoprotein
A-I (P<0.001). None of the SNPs showed signiﬁcant association with the reduction of plasma lipids in
response to the dietary interventions and there was no evidence of diet-gene interactions.
Conclusion: Results from this exploratory study have shown that increased genetic predisposition was
associated with an unfavourable plasma lipid proﬁle at baseline, but did not inﬂuence the improvement
-satin lipid proﬁles by the low
. Introduction
Plasma lipids are risk factors for cardiovascular disease (CVD)
nd are known to be sensitive to dietary change [1]. Plasma choles-
erol can be altered by changes to the quality and quantity of
at in the diet; in particular total plasma cholesterol can be low-
red by reductions in dietary total or saturated fat [2,3]. However,
eplacementof SFAwith carbohydrate also reducesHDLcholesterol
HDL-C)with an associated increase in CVD risk [4]. Replacement of
FA with monounsaturated fatty acids (MUFA) achieves a decrease
n total (TC) and LDL cholesterol (LDL-C) without a decrease in
DL-C [4,5]. Genetic factors also exert a strong inﬂuence on the
egulation of plasma lipids, with heritability estimates for fasting
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plasma lipids ranging from 35 to 60% [6–8]. There is growing inter-
est in the interplay between genetic and environmental factors,
which may help to explain the variation between individuals in
response to diet [6].
Genome-wide association (GWA) studies have identiﬁed a
number of SNPs robustly associated with traits of dyslipi-
daemia in cross-sectional studies [9–16]. However, it remains
unknown whether these common lipid-associated SNPs also alter
the responses to dietary interventions. We hypothesised that
the mechanisms underlying genetic predisposition to dyslipi-
daemia would impair the improvement in plasma lipid status
which can be produced by modifying the amount and type of
dietary fat. This hypothesis was tested in a cohort of 490 par-
Open access under CC BY license.ticipants in the RISCK trial; a highly controlled intervention to
reduce dietary saturated fat based on replacement with either
carbohydrate (CHO) or monounsaturated fat (MUFA) [2]. We
examined the association of 39 lipid-associated SNPs, individu-
ally as well as combined, on plasma lipid measures at baseline
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Table 1
Characteristics of subjects included in this study.
Whitea (n=395) S, SE Asiana (n=46) Black Africana (n=38)
Gender (M/F %) 59/41 64/36 59/41
Age (years) 53.0 (9.9) 50.5 (8.7) 50.5 (9.5)
BMI (kg/m2) 29.0 (4.8) 28.0 (4.2) 30.1 (5.4)
Body fat (%) 34.1 (8.3) 33.2 (8.6) 35.0 (8.2)
Waist circumference (cm) 98.0 (12.4) 97.1 (16.3) 100.7 (12.9)
Glucose (mM) 5.69 (0.77) 5.67 (0.83) 5.44 (0.84)
Insulin (pM)b 58.3 [55.4, 61.3] 72.0 [59.8, 86.8]* 68.3 [57.4, 81.3]
TC (mM) 5.74 (0.97) 5.19 (0.89)* 5.23 (1.00)*
HDL-C (mM) 1.41 (0.32) 1.28 (0.28)* 1.29 (0.29)
LDL-C (mM) 3.63 (0.81) 3.31 (0.79)* 3.32 (0.86)
TG (mM)b 1.41 [1.35, 1.47] 1.21 [1.07, 1.36] 1.25 [1.09, 1.43]
apo B (g/L) 0.99 (0.30) 0.96 (0.28) 0.91 (0.25)
apo AI (g/L) 1.23 (0.26) 1.22 (0.21) 1.23 (0.25)
TC:HDL-C (mM) 4.22 (0.92) 4.19 (0.92) 4.17 (0.97)






































Sere tested by ANOVA with Tukey’s post hoc test performed if P<0.05. Differences
ere no signiﬁcant differences between S, SE-Asians and Black-Africans.
a Stratiﬁed by self-reported ethnicity.
b TG and insulin data not normally distributed therefore presented as the geome
nd on the change in response to 24 weeks dietary interven-
ion.
. Methods
.1. Original RISCK trial study design
Full details of the RISCK trial have been published elsewhere [2].
rieﬂy, men and women aged 30–70 years (n=720) were recruited
rom the general population. To participate in the trial, subjects
ad to be at increased risk of developing metabolic syndrome and
VD according to a study-speciﬁc scoring system [2]. Self-reported
thnicity was recorded as White; South and South East Asian, Black
frican, or other.
The reference and intervention diets (described in detail in
oore et al. [17]) were designed to be iso-energetic, but varied
n the amount and type of fat and carbohydrate. For the purposes
f the current study the dietary intervention groups differing in
arbohydrate quality were combined to focus the analyses on the
anipulation of dietary fat, from which the impact in CVD risk was
xpected to be greater. The resulting three dietary groups were;
reference diet’ (REF) designed to reﬂect saturated fat intake in a
Western diet’ (∼18% of energy (E) SFA, 12% MUFA, 38% total fat,
5% CHO); ‘MUFA diet’ in which SFA was reduced and replaced
ith MUFA (∼10% SFA, 20% MUFA, 38% total fat, 45% CHO); ‘LF
iet’, in which SFA was reduced through replacement of total fat
ith carbohydrate (∼10% SFA, 11% MUFA, 28% total fat, 55% CHO).
All participants underwent a 4-week run-in period on the REF
iet, after which anthropometry was measured and fasting blood
amples were taken. Measurements taken after the run-in diet are
eferred to in this study as ‘baseline’ measurements. All partici-
ants followed their randomly prescribed diets for 24 weeks, after
hich a further blood sample was collected and anthropometry
easured.
Ethical approval for the RISCK study (ISRCTN29111298) was
ranted from the National Research Ethics Service and written
nformed consent from participants was obtained including sub-
equent genetic analyses.
.2. Characteristics of study cohortOf the 720 participants, 549 completed the study and DNA was
vailable for 512 participants. Based on self-reported ethnicity, we
istinguished individuals of White (80%), South and South East (S,
E) Asian (9.5%); Black African (8%) and “other” (2.5%) ancestry.een Whites and S, SE-Asians or Black-Africans were marked with * (P<0.05). There
ean [95% conﬁdence intervals].
Analyses were stratiﬁed by self-reported ethnicity into three sub-
groups with participants in the “other” subgroup excluded from
this analysis (n=11). The baseline characteristics of the partici-
pants in this study, stratiﬁed by the three main ethnic groups, are
presented in Table 1.
Themajority (91%) of the participantswere overweight or obese
and/or had elevated waist circumference (>94 cm for males and
>84 cm for females) indicating the presence of central obesity.
We observed no signiﬁcant differences for age, gender, BMI,
body fat (%), waist circumference, glucose, triglycerides, apo B or
apo A-I between the ethnic groups. Insulin concentrations were
higher in S, SE-Asians compared to Whites, TC higher in Whites
compared to S, SE-Asians and Black Africans and LDL-C and HDL-C
lower in S, SE-Asians compared to Whites (Table 1).
2.3. Plasma lipid analyses and response to dietary intervention
TC, HDL-C and triglyceride (TG) were analysed at King’s College
London by enzymatic assay on a Bayer Advia Model Analyser using
reagents supplied by the manufacturer (Bayer Diagnostics Europe,
Newberry, Berks, UK). LDL-C was calculated using the Friedwald
formula only it fasting TG concentrations were <4.49mmol/L.
PlasmaapolipoproteinsB (apoB) andA-I (apoA-I)weredetermined
by immunoprecipitationassays (RandoxLaboratories, Crumlin,UK)
at the University of Surrey (see Jebb et al. [2] for further details).
As reported in full in Jebb et al. [2] plasma TC, LDL-C and apo B
were signiﬁcantly reduced in response to 24 weeks on the LF and
MUFAdiets. Therewas also a signiﬁcant reduction in plasmaHDL-C
and apo A-I in response to the LF but not the MUFA diet. There was
no change in plasma TG.
2.4. SNP selection and genotyping
Forty lipid-associated SNPs were identiﬁed from GWA stud-
ies published prior to April 2009. SNPs were only selected from
GWA studies with at least 1000 individuals in the discovery stage,
with replication in at least one independent population, and which
reached the threshold of genome-wide signiﬁcance of P<5×10−8
[9–16]. Priority was given to SNPs that were plausible biological
targets of lipid metabolic pathways, and that were identiﬁed by
at least two independent GWA studies or meta-analyses. Where
multiple SNPs resided in or near the same gene, SNPs in low link-
age disequilibrium (LD r2 <0.3) were selected with a maximum of
three SNPs per gene.
C.G. Walker et al. / Atherosclerosis 215 (2011) 421–427 423
a b







≤8 9-10 11-12 13-14 ≥15
































≤9 10-11 12-13 14-15 ≥16


































































aig. 1. (a) Variation of apo B at baseline by LDL-C genetic predisposition score (GP
he squares represent the mean and standard error values of (a) apo B and (b) apo
DL-C risk alleles per individual (x-axes). The histograms denote the number of ind
Genotyping was performed in the 501 participants of the three
ain ethnic groups who completed the study, and for which there
as DNA available. Genotyping was performed by KBiosciences
Hoddesdon, Herts, UK) using a ﬂuorescence-based competitive
llele-speciﬁc PCR (KASPar) technology and all SNPs had a call
ate >95%. Individuals were excluded if genotyping was unsuccess-
ul in >10% of SNPs (11 subjects). All genotype distributions were
ested for deviation from the Hardy–Weinburg equilibrium using
he log likelihood ratio chi-square test for association (P<0.001);
nd one SNP was excluded (rs174547) from analyses due to devi-
tion (P<0.0001). This resulted in 14 HDL-C-associated SNPs in or
ear 11 genes; 12 LDL-C-associated SNPs in or near 11 genes; 5 TC-
ssociated SNPs in or near 5 genes; and 10 TG-associated SNPs in or
ear 9 genes (Supplementary Table 1). Some SNPs were associated
ith more than one lipid trait.
.5. Genetic predisposition score
A risk-allele was deﬁned as the allele associated with raised TC,
DL-C, TG or low HDL-C in previous GWA studies [9–16]. An addi-
ivemodelwas assumedand individual SNPswere coded as 0, 1 and
on the basis of the number of the risk-alleles for that particular
NP based on previous GWA studies [9–16]. As there is currently
o evidence for interaction between SNPs, a simple addition of the
ssociated risk alleles for each trait has been commonly adopted
18–20]. For each individual, genetic predisposition scores (GPS)
ere calculated for each of the traits separately (HDL-C, LDL-C, TC,
G) by adding all of the scores for each risk-allele associated with
hat trait (Supplementary Table 1). We did not weight the risk alle-
es on the basis of their individual effect sizes because it has been
hown that weighting of risk alleles may have only limited effect
21] andbecause the effect size of SNPs on traits at baselinemaynot
e relevant to the effect on the change in trait.We therefore elected
or the approach employed previously [19] of simple addition of
isk alleles allowing for a more straightforward interpretation. For
articipants missing individual genotyping data, the average count
f risk alleles for the respective SNP was substituted for the miss-
ng genotype for the purposes of calculating the GPS. All GPS were
ormally distributed.
The SNPs selected for analysis are presented in Supplementary
able 1 showing the risk-allele frequency in each ethnicity for this
ohort. Previous studies have shown that LDL-C-associated SNPs
lso associatewith apoBandHDL-C-associated SNPs associatewithd (b) variation of apo A-I at baseline by HDL-C genetic predisposition score (GPS).
ght y-axes) for each GPS score category deﬁned by the number of (a) LDL-C and (b)
ls in each GPS score category (left y-axes).
apo A-I [16,18]. Therefore LDL-C-associated SNPs and LDL-C-GPS
were alsoused to examine theeffect onapoBandHDL-C-associated
SNPs and HDL-C-GPS were used to assess the association with apo
A-I.
2.6. Statistical analysis
Distributions of traits were tested for normality; and baseline
TG was log-transformed for analyses and presented in tables in
this form except for the subject characteristics in Table 1 where
the geometric mean of TG was shown.
Linear regression analysis was used to test for associations
between each SNP (coded as 0, 1 and 2 according to the number of
risk-alleles) and the relevant traits atbaseline, assuminganadditive
effect of each additional risk allele, while adjusting for age, gender
and BMI. Due to the size of our cohort, we did not have sufﬁcient
power to detect signiﬁcant associations between individual SNPs
and lipid traits at baseline (Supplementary Fig. 1). For example SNP
rs2338104, which has a minor allele frequency (MAF) of 47% in
the cohort of white subjects has >80% power to detect an increase
in trait of 0.2 SD-score per allele, but only 5% power to detect an
increase in trait of 0.01 SD-score per allele. SNP rs1800961, which
has a MAF of 3% in the cohort of white subjects has <25% power
to detect an increase in trait of 0.2 SD-score per allele and <5% to
detect an increase in trait of 0.01 SD-score per allele.
Next, we tested for association between each SNP and change
in lipid concentration following 24 weeks of intervention (change
calculated as ﬁnal value minus baseline), adjusted for baseline val-
ues of respective trait, age, gender and BMI. There was no linearity
assumption of relevant traits with diet, therefore the LF and MUFA
diets were added in the model individually, in comparison to the
REF diet.
Due to insufﬁcient power to examine associations of individ-
ual SNPs, we focussed our study on the GPS, which provides more
power. Associations between the GPSs and respective traits (base-
line and change)were testedwith linear regression in the sameway
individual SNPs were tested, adjusting for the same covariates.
All baseline and change associationswere tested for interactions
between gender and GPS and gender and individual SNP. Associa-
tionswith change in traitswerealso tested for interactionsbetween
diets and GPS and diets and individual SNP.
All analyses were stratiﬁed by the three main ethnic groups. In
order to obtain an overall result for the cohort, summary statistics
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Table 2
Effect of genetic predisposition score (GPS) on total, LDL and HDL cholesterol, triglycerides, apo A-I and apo B at baseline in three ethnicities and meta-analysed.
White S, SE-Asian Black African Meta-analysis
Effect SE P n Effect SE P n Effect SE P n Effect 95%CI 95%CI P Heterogeneity
TC (mM) 0.09 0.04 0.03 394 0.13 0.12 0.28 46 −0.04 0.13 0.74 39 0.08 0.01 0.15 0.02 0.56
LDL-C (mM) 0.06 0.02 0.009 392 0.09 0.05 0.09 46 0.07 0.09 0.46 39 0.06 0.02 0.10 0.002 0.80
HDL-C (mM) −0.03 0.01 0.00002 394 −0.06 0.01 0.00005 46 −0.04 0.02 0.10 39 −0.03 −0.04 −0.02 8.9×10−9 0.10
lnTG (mM) 0.04 0.01 0.004 393 0.03 0.03 0.43 46 0.04 0.04 0.26 39 0.04 0.02 0.06 0.001 0.92
apo A-I (g/L) −0.02 0.01 0.001 375 −0.04 0.01 0.005 46 −0.02 0.02 0.40 37 −0.02 −0.03 −0.01 0.00003 0.40
apo B (g/L) 0.02 0.01 0.005 375 0.02 0.02 0.23 46 0.01 0.02 0.68 37 0.02 0.01 0.03 0.004 0.93
Data are the co-efﬁcient of associations of genetic predisposition score (GPS) for each trait, presented as per allele effect size, standard error and P derived from linear
r e adju




































Tegression models. The linear regression models were of GPS against trait at baselin
or apo A-I regression analysis. TG data was logged for the analysis and is presente
tatistics were meta-analysed and the per allele effect size (ES), 95% conﬁdence inte
he number of participants (n) in each subgroup is indicated.
f the ethnicity-speciﬁc associations were pooled using a random-
ffects meta-analysis based on the method of DerSimonian and
aird [22] (metan function in Stata). In order to determine whether
he results of the three ethnicities could be combined, a test for
eterogeneity was performed and the results of the meta-analysis
erenot presented if the associations betweenGPSor SNPand lipid
rait were different between the ethnicities (P<0.05 for the test of
eterogeneity).
Statistical analysis was conducted using Stata 11 (StataCorp,
exas, USA). We performed a large number of tests but elected
o not use any correction for multiple testing as this was an
xploratory study to examine genetic predisposition to dyslipi-
aemia, and the interaction between GPS and lipids in response
o a dietary intervention.
. Results
.1. Effect of genetic predisposition on lipids and apolipoproteins
t baseline
The trait-speciﬁc GPSs were all associated with the respective
raits, i.e. the higher the score the less favourable the lipid proﬁle
Table 2). Each additional risk-allele in the TC-GPS was associated
ith 0.08mM higher TC concentration; the LDL-C-GPS was asso-
iated with a 0.06mM higher LDL-C concentration per additional
isk-allele and the TG-GPS with a 0.04mM higher lnTG concentra-
ion per additional risk-allele (Table 2).The LDL-C-GPS was also associated with higher apo B concen-
ration and the HDL-C-GPS with lower apo A-I levels per additional
isk allele (Fig. 1).
We observed association coefﬁcients which, although generally
ot signiﬁcant, were directionally consistent with previous GWA
able 3
ffect of genetic predisposition score (GPS) on the change in total, LDL and HDL cholestero
thnicities and meta-analysed.
White S, SE-Asian Blac
Effect SE P n Effect SE P n Effe
TC (mM) −0.03 0.02 0.28 370 0.00 0.07 0.96 46 −0.1
LDL-C (mM) −0.01 0.01 0.38 368 0.01 0.03 0.67 46 0.0
HDL-C (mM) −0.01 0.00 0.24 370 −0.01 0.01 0.58 46 −0.0
TG (mM) 0.01 0.01 0.66 369 −0.02 0.03 0.63 46 −0.0
apo A-I (g/L) −0.01 0.00 0.02 375 0.01 0.01 0.40 46 −0.0
apo B (g/L) −0.01 0.00 0.27 375 0.00 0.01 0.94 46 0.0
ata are the co-efﬁcient of association of genetic predisposition score (GPS) for each trai
s per allele effect size, standard error and P derived from linear regression models. The
rait at baseline, age, gender and BMI. The LDL-C GPS was used for apo B and the HDL-C G
alue−baseline value, and negative effects represent an association with a reduction in tr
he summary statistics were meta-analysed and the effect size, 95% conﬁdence intervals (
he number of participants (n) in each subgroup is indicated.sted for age, gender and BMI. The LDL-C GPS was used for apo B and the HDL-C GPS
og-transformed data. Data are presented for each ethnic sub-group. The summary
CI), P and measure of heterogeneity (P-value from test of heterogeneity) are shown.
studies for four out of ﬁve individual TC SNPs; for nine out of 12
LDL-C SNPs; for nine out of 13 HDL-C SNPs and for ﬁve out of
seven TG SNPs,whendata of all three ethnic groupswere combined
(Supplementary Table 2).
The association coefﬁcients of 10 out of 12 LDL-C risk SNPs were
in a positive directionwith apoB, althoughnot generally signiﬁcant
(Supplementary Fig. 2a). Eleven out of 13 HDL-C risk SNPs were in
a negative direction with apo A-I (Supplementary Fig. 2b), four of
which were also negatively associated with HDL-C (rs1800775 and
rs9989419 – CETP locus; rs10468017 – LIPC locus; rs4846914 –
GALNT2 locus).
There was little evidence of heterogeneity between the ethnic
groups except two TG SNPs and one HDL-C SNP that was direction-
ally consistent in Whites and S, SE Asians but not in Black Africans
(Supplementary Table 2).
There were no signiﬁcant interactions between gender and GPS
or individual SNPs on the association with lipid traits at baseline
(data not shown).
3.2. Effect of genetic predisposition on the change in lipids and
apolipoproteins in response to dietary intervention to lower SFA
Following the dietary intervention, the decrease in apo A-I was
greater the higher the HDL-C-GPS, with an effect size of −0.01g/L
per HDL-C risk allele (P<0.05) (Table 3). The lipid-lowering effects
of the LF diet andHDL-C-GPSwere additive (Fig. 2) but therewas no
signiﬁcant diet×HDL-C-GPS interaction effect for apo A-I (P>0.09
for all ethnicities) or any other traits (data not shown). TC tended
(P=0.1) to be further reduced by 0.03mMper allelewith higher TC-
GPS (Table 3). There was also a trend (P=0.09) towards a greater
reduction in HDL-C of 0.01mM per allele with higher HDL-C-GPS.
TG-GPS was not associated with change in TG or LDL-C-GPS with
reduction of LDL-C or apo B (Table 3).
l, triglycerides, apo A-I and apo B following 24 weeks dietary intervention in three
k African Meta-analysis
ct SE P n Effect 95%CI 95%CI P Heterogeneity
4 0.07 0.047 38 −0.03 −0.075 0.007 0.10 0.25
0 0.06 0.94 38 −0.01 −0.030 0.015 0.51 0.76
2 0.01 0.18 38 −0.01 −0.012 0.001 0.09 0.66
3 0.05 0.55 38 0.00 −0.028 0.027 0.99 0.67
1 0.02 0.78 37 −0.01 −0.013 0.000 0.048 0.28
2 0.02 0.28 37 0.00 −0.012 0.005 0.46 0.39
t with the change in that trait following 24 weeks dietary intervention, presented
linear regression models were of GPS against the change in trait adjusted for that
PS for apo A-I regression analysis. Data for change values were calculated by ﬁnal
ait following 24 weeks intervention. Data are presented for each ethnic sub-group.
CI), P and measure of heterogeneity (P-value from test of heterogeneity) are shown.
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Fig. 2. Apo A-I stratiﬁed by genetic predisposition score (HDL-C-GPS) before and after the dietary intervention in the total cohort, and split into dietary intervention groups.































cata are presented as mean± SE before and after 24 weeks on a dietary interventio
UFA diet group; and (d) the LF diet group. HDL-C-GPS was stratiﬁed into 4 grou
ollows: total (GPS-1:129, GPS-2:138, GPS-3:149, GPS-4:53); REF (GPS-1:17, GPS-2
PS-2:56, GPS-3:70, GPS-4:15).
There was no evidence of heterogeneity across the three ethnic
roups for the effect of anyGPSon the change in lipid or apolipopro-
ein traits.
Of the ﬁve TC SNPs, one in the APOB locus tended (P=0.06) to
ugment the diet-induced reductions in TC levels; of the 11 LDL-
SNPs, only one in the PCSK9 locus was associated (P=0.04) with
mpeding the diet-induced reductions in LDL-C. No individual SNPs
ere associated with change in HDL-C, TG, apo B or apo A-I follow-
ng the dietary intervention (Supplementary Table 3).
There was some indication (P<0.1) of heterogeneity between
heethnic groups for theeffect of individual SNPsonchange in traits
ith one TC SNP on the change in TC; 1 LDL-C SNP on the change in
DL-C and four on the change in apo B; one HDL-C SNP on change
n HDL-C and two on change in apo A-I (Supplementary Table 3).
enerally, there was directional consistency between results in the
hites and S, SE Asians but not Black-Africans.
There was an interaction effect between gender and rs6511720
P=0.002) and the change in apo B, but no other signiﬁcant interac-
ions betweengender andGPSor individual SNPs on the association
ith change in lipid traits.
While the intervention diets were designed to be iso-energetic,
herewas a small (<1kg) but statistically signiﬁcant (P<0.001) inci-
ental weight loss on the low fat diet during the trial [2]. As weight
oss has been shown to improve lipid proﬁles [23], the analyses
ere repeated with and without weight change. There was no dif-
erence in the effect of any SNP or GPS on change in plasma lipids
data not shown).
. Discussion
Our results show that genetic predisposition scores (which
eﬁned genetic susceptibility) were signiﬁcantly associated with
he respective lipid trait at baseline on a ‘reference’ diet high in
FA. We also conﬁrmed that many of the SNPs identiﬁed in GWA
tudies showed effects of a similar magnitude and direction in this
ohort of subjects at increased cardiometabolic risk, although typi-a) the response in the total cohort and split into (b) the REF diet group; (c) the high
1; 12–13; 14–15; ≥16 risk alleles]. The number of subjects in each group was as
PS-3:22, GPS-4:9); MUFA (GPS-1:58, GPS-2:54, GPS-3:57, GPS-4:29); LF (GPS-1:54,
cally not reaching signiﬁcance in this study. We found no evidence
that genetic predisposition to dyslipidaemic traits impaired the
beneﬁcial effects of a dietary intervention of reduced SFA intake
to lower plasma TC, LDL-C and apo B.
This is the ﬁrst study to examine how SNPs previously shown
to be unequivocally associated with fasting lipid concentrations,
modify lipid responses to dietary interventions. Due to the nature
ofhighly controlleddietary interventions,wewere limited toa rela-
tively small sample size for investigating dietary-gene interactions.
However, in terms of highly controlled dietary interventions this
cohort was relatively large, providing the opportunity to under-
take a preliminary investigation into the effect of these SNPs on
dynamic responses to changes in dietary fat in a highly controlled
situation.
Very few studies have examined the relationship between com-
monly occurring SNPs and plasma apolipoproteins. Previous GWA
studies [16] and studies using the CardioChip [18] showed a close
association between LDL-C-SNPs and apo B and HDL-C-SNPs and
apo A-I. In the RISCK study cohort, we have shown that LDL-C-
GPS (a cumulative GPS, composed of LDL-C-SNPs), was positively
associated with apo B and that HDL-C-GPS (a cumulative GPS com-
posed of HDL-C-SNPs) was negatively associated with apo A-I at
baseline. In response to 24 weeks dietary intervention both the LF
diet (P<0.05) and the HDL-C-GPS (P<0.05) were associated with
a reduction in apo A-I. Although not signiﬁcant, the association
of HDL-C-GPS on change in HDL-C (P=0.09) was also negative.
A disadvantage of a low fat diet can be a resultant decrease in
HDL-C [4], as low HDL-C and apo A-I are in themselves markers of
metabolic syndrome and CVD risk [24–26]. This small preliminary
study suggests that those genetically predisposed to low HDL-C,
and who also have low apo A-I may have further adverse effects on
lipid proﬁle following a LF diet. However, as there was no adjust-
ment for multiple testing in this study, these results are to be
viewedaspreliminary, and further research iswarranted to explore
the role of these common SNPs as ‘effect modiﬁers’ in dietary
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In this study, we focussed on SNPs with the strongest asso-
iations in GWA studies rather than selecting SNPs with known
unctionality. Furthermore, the opportunities to examine single
NPs were limited due to small sample size and the small effect
ize of the SNPs. We therefore focussed on the cumulative genetic
redisposition using the GPS. Nonetheless, it is of note that many
f the selected SNPs were located in or near genes involved in lipid
etabolic pathways [6]. Many SNPs were also located in genes
here rare monogenic mutations underlie causes of severe dys-
ipidaemia [27]. Notably, SNPs of CETP (Cholesteryl Ester Transfer
rotein) and LIPC (hepatic lipase) loci were signiﬁcantly associated
ith baseline HDL-C and apo A-I as found previously both in GWA
tudies [9,11,13,16] and in candidate gene studies [28,29]. How-
ver, these individual SNPs did not signiﬁcantly alter theHDL-C and
po A-I response to dietary intervention. The rs4846914 SNP from
he GALNT2 locus was also signiﬁcantly associated with both base-
ineHDL-C and apoA-I in the current study. An association between
his SNP and HDL-C was recently reported in a large meta-analysis
f GWA studies of common variants and lipid traits, with follow-up
unctional studies in mice that implicated GALNT2 as a biologi-
al mediator of HDL-C concentration [30]. In the current study,
here was also no association of this SNP with change in apo A-I,
ut it was associated with an increase (0.03±0.01mM, P=0.03) in
DL-C in the White participants only, indicating a potential cardio-
rotective effect (Supplementary Table 3). It is noteworthy that
any of these SNPs reside outside the coding regions of genes and
hus the effects on lipid changes are difﬁcult to interpret.
In the current study, there was little evidence of heterogeneity
or individual SNPs or GPSs on lipid traits between different ethnic
roups, which is consistent with a recent large study that showed
o evidence of heterogeneity between European, South and South-
ast Asian and African American populations in 95 lipid-related
NPs [30]. There was a greater degree of heterogeneity between
thnic groups in the effects of SNPs on the change in lipid traits,
owever this ﬁnding can only be viewed as exploratory in view of
he very small sample size of Asian and Black subgroups. Never-
heless preliminary results from this study may indicate that the
ffects of some SNPs in response to diets were greater in some
thnicities. For example SNPs rs693 (APOB locus) and rs3846662
HMGCR locus) had a greater reduction in plasma TC (effect size
0.26 and −0.31mM per risk allele) in Black-Africans group but
o signiﬁcant effect in Whites (Supplementary Table 3). As many
f the SNPs reside outside coding regions of the genes, this may
eﬂect that these SNPs were simply markers for other SNPs, and
hat the LD between the marker and functional SNP varies with
thnicity [31]. However, due to the very small sample size of the
lack-African and South and South-East Asian subgroups in partic-
lar, any preliminary observations require investigation in larger
ohorts.
The RISCK study was designed to represent achievable public
ealth goals in terms of themanipulation of dietary fat. The current
tudy indicates that regardless of common genetic predisposition
o dyslipidaemia, improvements in lipid proﬁle can be achieved
y changes to dietary fat quality and content. This analysis on
NPs which may moderate lipid responses to diet is not exhaus-
ive; however it covers SNPs most important for regulating lipids
t a population level and may therefore have public health impli-
ations for the management of common dyslipidaemia by dietary
eans.
In conclusion, high plasma TC, TG, LDL-C and apo B and lowpo A-I and HDL-C were inﬂuenced by genetic predisposition in
his cohort of overweight men and women, who were identiﬁed
t increased cardiometabolic risk. A dietary manipulation to lower
FA was successful in lowering plasma TC, LDL-C, and apo B, most
otably in those genetically predisposed to dyslipidaemia.sis 215 (2011) 421–427
Source of funding
The RISCK dietary intervention trial was funded by the Food
Standards Agency project number NO2031. Genetic analyses were
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